Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Open Label, Multi-Center, Long-Term Extension Study to Evaluate the Safety of PHX1149T/Dutogliptin in Subjects With Type 2 Diabetes Mellitus

NCT00865592 is registered in ClinicalTrials.gov with Phenomix as lead sponsor.

NCT NCT00865592
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00865592 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Open Label, Multi-Center, Long-Term Extension Study to Evaluate the Safety of PHX1149T/Dutogliptin in Subjects With Type 2 Diabetes Mellitus
Lead sponsor
Phenomix
Phase
Phase 3
Overall status
Terminated
Start date
March 31, 2009
Completion date
March 31, 2011
Enrollment
450 (estimated)
Sites
68

Conditions

As the registry lists them; a condition with its own page is linked.

type 2 diabetes, type 2 diabetes mellitus